UK also ranked high performing in Aortic Valve Surgery, Colon Cancer Surgery, Heart Bypass Surgery, and Lung Cancer Surgery

By Kristi Willett
Click here for UKnow story

UK HealthCare’s University of Kentucky Albert B. Chandler Hospital remains the No.

The UK Center for Clinical and Translational Science (CCTS) is now accepting applications for Early Career and High Impact Pilot Projects. The purpose of this funding mechanism is to provide a new opportunity and resources to support innovative, collaborative research relevant to the health challenges and disparities faced by the nation and the citizens of Kentucky.

A team of scientists have designed and tested a novel and promising therapeutic strategy for treating Lafora Disease (LD), a fatal form of childhood epilepsy. This new type of drug, known as an antibody-enzyme fusion, is a first-in-class therapy for LD and an example of precision medicine that has potential for treating other types of aggregate-based neurological diseases.

The 43rd Appalachian Studies Association (ASA) Conference will be held at the University of Kentucky March 12-15, 2020, for the first time in the organization's history, inpartnership with  the University of Kentucky’s Appalachian CenterCollege of Arts and Sciences and Graduate Appalachian Research Community (GARC) 

At the end of June, University of Kentucky Otolaryngology held a banquet honoring our three chief residents. After five years, Drs. Nicole Colgrove, Kyle Fletcher, and Michael Kaufman successfully completed their residency training. Dr. Colgrove will go on to complete a Facial Plastic and Reconstructive Surgery Fellowship at Virginia Commonwealth University. Dr. Fletcher will be joining Ephraim McDowell Ear, Nose, & Throat in Danville, KY alongside UK Oto alumnus Jonathan Doty, and Dr. Kaufman will be joining private practice with Wellstar Health in Atlanta, GA. Dr.
By Kristi Willett LEXINGTON, Ky. (July 24, 2019) – The Pulmonary Fibrosis Foundation (PFF) has announced the expansion of its nationwide Care Center Network with the selection of eight additional sites, including UK HealthCare's Pulmonary, Critical Care and Sleep Medicine Clinic. More than 200,000 Americans are living with pulmonary fibrosis, a devastating disease which causes progressive scarring in the lungs. Fifty-thousand new cases of PF are diagnosed each year. Idiopathic pulmonary fibrosis, the most common form of the disease, has no known cause and no known cure.

Kristi Grider still tears up when she talks about the day she took her two-month-old son, Kenton, now seven years old, for follow-up hearing testing. His newborn hearing screen, which almost all children receive in U.S. hospitals before they go home, had indicated a potential abnormality, but she was told that her baby probably just had fluid in his ears and that she needn’t worry. 

An estimated 21 million Americans struggle with substance use disorders each year. Unfortunately, according to the Substance Abuse and Mental Health Services Administration, only about 10 percent of those people are able to access treatment. Few regions have been hit harder by the drug epidemic than Kentucky and need increased access to evidence-based treatment for substance use disorders. The University of Kentucky Department of Psychiatry saw that need and developed a new clinic to better support patients.